Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.80)
# 3,114
Out of 4,868 analysts
170
Total ratings
42.25%
Success rate
-2.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $160 | $145.53 | +9.94% | 16 | Jun 11, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $90.55 | +4.91% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $509.49 | +27.58% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $4.26 | +17.37% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.74 | +23.20% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $124.00 | -23.39% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $85.73 | +14.31% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $84.77 | +0.27% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $29.70 | -49.49% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $301.79 | +13.66% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.75 | +409.09% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $29.80 | +61.07% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $73.98 | +37.88% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $101.37 | -42.78% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $11.55 | +73.16% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $81.01 | +61.71% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $132.41 | +0.45% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $373.26 | -41.06% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $117.72 | +221.10% | 2 | Feb 25, 2022 |
iRhythm Technologies
Jun 11, 2025
Maintains: Overweight
Price Target: $130 → $160
Current: $145.53
Upside: +9.94%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $90.55
Upside: +4.91%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $509.49
Upside: +27.58%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.26
Upside: +17.37%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.74
Upside: +23.20%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $124.00
Upside: -23.39%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $85.73
Upside: +14.31%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $84.77
Upside: +0.27%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $29.70
Upside: -49.49%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $301.79
Upside: +13.66%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.75
Upside: +409.09%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $29.80
Upside: +61.07%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $73.98
Upside: +37.88%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $101.37
Upside: -42.78%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $11.55
Upside: +73.16%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $81.01
Upside: +61.71%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $132.41
Upside: +0.45%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $373.26
Upside: -41.06%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $117.72
Upside: +221.10%